Example of ClinicoEconomics and Outcomes Research format
Recent searches

Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format Example of ClinicoEconomics and Outcomes Research format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

ClinicoEconomics and Outcomes Research — Template for authors

Publisher: Dove Medical Press
Categories Rank Trend in last 3 yrs
Economics, Econometrics and Finance (miscellaneous) #34 of 159 down down by 21 ranks
Health Policy #97 of 242 down down by 22 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 283 Published Papers | 758 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 25/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

Taylor and Francis

Quality:  
High
CiteRatio: 3.2
SJR: 1.216
SNIP: 3.119
open access Open Access

SAGE

Quality:  
High
CiteRatio: 3.4
SJR: 0.75
SNIP: 1.562
open access Open Access
recommended Recommended

SAGE

Quality:  
High
CiteRatio: 4.3
SJR: 0.603
SNIP: 1.079

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

2.7

4% from 2019

CiteRatio for ClinicoEconomics and Outcomes Research from 2016 - 2020
Year Value
2020 2.7
2019 2.6
2018 2.5
2017 2.8
2016 3.6
graph view Graph view
table view Table view

0.591

9% from 2019

SJR for ClinicoEconomics and Outcomes Research from 2016 - 2020
Year Value
2020 0.591
2019 0.544
2018 0.609
2017 0.654
2016 0.885
graph view Graph view
table view Table view

0.83

4% from 2019

SNIP for ClinicoEconomics and Outcomes Research from 2016 - 2020
Year Value
2020 0.83
2019 0.868
2018 0.639
2017 0.775
2016 1.078
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has increased by 4% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has increased by 9% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 4% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

ClinicoEconomics and Outcomes Research

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Dove Medical Press

ClinicoEconomics and Outcomes Research

ClinicoEconomics and Outcomes Research is an international, peer-reviewed open-access journal focusing on Health Technology Assessment, Pharmacoeconomics and Outcomes Research in the areas of diagnosis, medical devices, and clinical, surgical and pharmacological intervention. ...... Read More

Economics, Econometrics and Finance

i
Last updated on
24 Jun 2020
i
ISSN
1178-6981
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
Blue faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
unsrt
i
Citation Type
Numbered
[25]
i
Bibliography Example
C. W. J. Beenakker. Specular andreev reflection in graphene. Phys. Rev. Lett., 97(6):067007, 2006.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.2147/CEOR.S34321
The clinical and economic burden of chronic obstructive pulmonary disease in the USA.
Anthony J. Guarascio1, Shaunta' M. Ray2, Christopher K. Finch2, Timothy H. Self

Abstract:

Chronic obstructive pulmonary disease (COPD) is the third most common cause of death in the USA. In 2010, the cost of COPD in the USA was projected to be approximately US$50 billion, which includes $20 billion in indirect costs and $30 billion in direct health care expenditures. These costs can be expected to continue to rise... Chronic obstructive pulmonary disease (COPD) is the third most common cause of death in the USA. In 2010, the cost of COPD in the USA was projected to be approximately US$50 billion, which includes $20 billion in indirect costs and $30 billion in direct health care expenditures. These costs can be expected to continue to rise with this progressive disease. Costs increase with increasing severity of disease, and hospital stays account for the majority of these costs. Patients are diagnosed with COPD following a multifactorial assessment that includes spirometry, clinical presentation, symptomatology, and risk factors. Smoking cessation interventions are the most influential factor in COPD management. The primary goal of chronic COPD management is stabilization of chronic disease and prevention of acute exacerbations. Bronchodilators are the mainstay of COPD therapy. Patients with few symptoms and low exacerbation risk should be treated with a short-acting bronchodilator as needed for breathlessness. Progression of symptoms, as well as possible decline in forced expiratory volume in the first second of expiration (FEV1), warrant the use of long-acting bronchodilators. For patients with frequent exacerbations with or without consistent symptoms, inhaled corticosteroids should be considered in addition to a long-acting beta2-agonist (LABA) or long-acting muscarinic antagonist (LAMA) and may even consist of "triple therapy" with all three agents with more severe disease. Phosphodiesterase-4 inhibitors may be an option in patients with frequent exacerbations and symptoms of chronic bronchitis. In addition to a variety of novel ultra-LABAs, LAMAs and combination bronchodilator and inhaled corticosteroid (ICS) therapies, other bronchodilators with a variety of mechanisms are also being considered, to expand therapeutic options for the treatment of COPD. With more than 50 new medications in the pipeline for the treatment of COPD, optimal management will continue to evolve and grow more complex as benefits of therapy are balanced with the limitations and needs of each patient. read more read less

Topics:

COPD (59%)59% related to the paper, Exacerbation (55%)55% related to the paper, Chronic bronchitis (55%)55% related to the paper, Indirect costs (53%)53% related to the paper, Spirometry (52%)52% related to the paper
View PDF
376 Citations
open accessOpen access Journal Article DOI: 10.2147/CEOR.S44625
The costs of traumatic brain injury: a literature review.
Ioan Humphreys1, Rodger L Wood, Ceri Phillips, Steven Michael Macey

Abstract:

OBJECTIVE: The purpose of this study was to review the literature relating to the psychosocial costs associated with traumatic brain injury (TBI). METHODS: Nine online journal databases, including MEDLINE, CINAHL, PsychINFO, and PUBMED, were queried for studies between July 2010 and May 2012 pertaining to the economic burden ... OBJECTIVE: The purpose of this study was to review the literature relating to the psychosocial costs associated with traumatic brain injury (TBI). METHODS: Nine online journal databases, including MEDLINE, CINAHL, PsychINFO, and PUBMED, were queried for studies between July 2010 and May 2012 pertaining to the economic burden of head injuries. Additional studies were identified through searching bibliographies of related publications and using Google internet search engine. RESULTS: One hundred and eight potentially relevant abstracts were identified from the journal databases. Ten papers were chosen for discussion in this review. All but two of the chosen papers were US studies. The studies included a cost-benefit analysis of the implementation of treatment guidelines from the US brain trauma foundation and a cost-effectiveness analysis of post-acute traumatic brain injury rehabilitation. CONCLUSION: Very little research has been published on the economic burden that mild and moderate traumatic brain injury patients pose to their families, careers, and society as a whole. Further research is needed to estimate the economic burden of these patients on healthcare providers and social services and how this can impact current health policies and practices. Language: en read more read less

Topics:

Rehabilitation (53%)53% related to the paper, Poison control (52%)52% related to the paper, CINAHL (52%)52% related to the paper
View PDF
249 Citations
open accessOpen access Journal Article DOI: 10.2147/CEOR.S38721
Epidemiology of falls and osteoporotic fractures: a systematic review

Abstract:

Background and methods Fractures in elderly populations result from the combination of falls and osteoporosis. We report a systematic review of studies indexed in PubMed reporting annual rates of low-trauma falls and associated osteoporotic fractures among older community-dwelling people (age ≥ 50 years). An osteoporotic fra... Background and methods Fractures in elderly populations result from the combination of falls and osteoporosis. We report a systematic review of studies indexed in PubMed reporting annual rates of low-trauma falls and associated osteoporotic fractures among older community-dwelling people (age ≥ 50 years). An osteoporotic fracture was defined as either a fracture resulting from a low-impact fall in subjects with clinical osteoporosis, a fall resulting in an investigator-defined osteoporotic fracture, or a fall resulting in a low-trauma fracture. Rates are presented using descriptive statistics. Meta-analysis was conducted for statistically homogeneous data sets. read more read less

Topics:

Poison control (50%)50% related to the paper
View PDF
167 Citations
open accessOpen access Journal Article DOI: 10.2147/CEOR.S39634
Medical technology as a key driver of rising health expenditure: disentangling the relationship.
Corinna Sorenson1, Michael Drummond, Bhuiyan Khan B

Abstract:

Health care spending has risen steadily in most countries, becoming a concern for decision-makers worldwide. Commentators often point to new medical technology as the key driver for burgeoning expenditures. This paper critically appraises this conjecture, based on an analysis of the existing literature, with the aim of offeri... Health care spending has risen steadily in most countries, becoming a concern for decision-makers worldwide. Commentators often point to new medical technology as the key driver for burgeoning expenditures. This paper critically appraises this conjecture, based on an analysis of the existing literature, with the aim of offering a more detailed and considered analysis of this relationship. Several databases were searched to identify relevant literature. Various categories of studies (eg, multivariate and cost-effectiveness analyses) were included to cover different perspectives, methodological approaches, and issues regarding the link between medical technology and costs. Selected articles were reviewed and relevant information was extracted into a standardized template and analyzed for key cross-cutting themes, ie, impact of technology on costs, factors influencing this relationship, and methodological challenges in measuring such linkages. A total of 86 studies were reviewed. The analysis suggests that the relationship between medical technology and spending is complex and often conflicting. Findings were frequently contingent on varying factors, such as the availability of other interventions, patient population, and the methodological approach employed. Moreover, the impact of technology on costs differed across technologies, in that some (eg, cancer drugs, invasive medical devices) had significant financial implications, while others were cost-neutral or cost-saving. In light of these issues, we argue that decision-makers and other commentators should extend their focus beyond costs solely to include consideration of whether medical technology results in better value in health care and broader socioeconomic benefits. read more read less

Topics:

Health technology (58%)58% related to the paper, Health care (53%)53% related to the paper, Health policy (52%)52% related to the paper
View PDF
143 Citations
open accessOpen access Journal Article DOI: 10.2147/CEOR.S85635
Review of the cost of venous thromboembolism.
Maria Fernandez1, Susan Hogue1, Ronald Preblick2, Winghan Jacqueline Kwong2

Abstract:

Background Venous thromboembolism (VTE) is the second most common medical complication and a cause of excess length of hospital stay. Its incidence and economic burden are expected to increase as the population ages. We reviewed the recent literature to provide updated cost estimates on VTE management. Background Venous thromboembolism (VTE) is the second most common medical complication and a cause of excess length of hospital stay. Its incidence and economic burden are expected to increase as the population ages. We reviewed the recent literature to provide updated cost estimates on VTE management. read more read less

Topics:

Population (54%)54% related to the paper
View PDF
125 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for ClinicoEconomics and Outcomes Research.

It automatically formats your research paper to Dove Medical Press formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

ClinicoEconomics and Outcomes Research format uses unsrt citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write ClinicoEconomics and Outcomes Research in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the ClinicoEconomics and Outcomes Research guidelines and auto format it.

2. Do you follow the ClinicoEconomics and Outcomes Research guidelines?

Yes, the template is compliant with the ClinicoEconomics and Outcomes Research guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in ClinicoEconomics and Outcomes Research?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the ClinicoEconomics and Outcomes Research citation style.

4. Can I use the ClinicoEconomics and Outcomes Research templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for ClinicoEconomics and Outcomes Research.

5. Can I use a manuscript in ClinicoEconomics and Outcomes Research that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper ClinicoEconomics and Outcomes Research that you can download at the end.

6. How long does it usually take you to format my papers in ClinicoEconomics and Outcomes Research?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in ClinicoEconomics and Outcomes Research.

7. Where can I find the template for the ClinicoEconomics and Outcomes Research?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per ClinicoEconomics and Outcomes Research's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the ClinicoEconomics and Outcomes Research's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. ClinicoEconomics and Outcomes Research an online tool or is there a desktop version?

SciSpace's ClinicoEconomics and Outcomes Research is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like ClinicoEconomics and Outcomes Research?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like ClinicoEconomics and Outcomes Research?”

11. What is the output that I would get after using ClinicoEconomics and Outcomes Research?

After writing your paper autoformatting in ClinicoEconomics and Outcomes Research, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is ClinicoEconomics and Outcomes Research's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for ClinicoEconomics and Outcomes Research?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for ClinicoEconomics and Outcomes Research. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In ClinicoEconomics and Outcomes Research?

The 5 most common citation types in order of usage for ClinicoEconomics and Outcomes Research are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the ClinicoEconomics and Outcomes Research?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per ClinicoEconomics and Outcomes Research's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download ClinicoEconomics and Outcomes Research in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in ClinicoEconomics and Outcomes Research Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to ClinicoEconomics and Outcomes Research formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template